The RCOG has some guidance (for drs) on how to treat post meno bleeding hyperplasia.
The Mirena alone isn't HRT.
It's used by some women with estrogen as part of HRT.
Am I correct in thinking that the hyperplasia detected in the removed polyp is of more concern than a lining thickness of 6.1mm?
I'm not sure about this! I'd have assumed that all polyps show hyperplasia as by definition they are classed (in most cases I think) as an overgrowth of the womb lining. But again, this is a question for the gynaecologist who is treating you.
Whoever is treating you needs to explain in detail what the plan is. The Mirena has enough hormones in it to last 5 years. Is this the plan or would it be removed after a certain length of time? (I find it amazing that doctors don't tell women all of this at the time!)
The other option is to not do anything and check the lining in 6 months which is called 'watch and wait' (this is mentioned in the guidance.)
The Mirena is supposed to have fewer side effects compared to oral progestogens. However, it does say in the guidance that they are used for 6 months and the same for the Mirena.Treatment with oral progestogens or the LNG-IUS should be for a minimum of 6 months in order to induce histological regression of endometrial hyperplasia without atypia.
This is from the document[[https://www.rcog.org.uk/media/knmjbj5c/gtg_67_endometrial_hyperplasia.pdf
- How should endometrial hyperplasia without atypia be managed?
7.1 What should the initial management of hyperplasia without atypia be?
Women should be informed that the risk of endometrial hyperplasia without atypia progressing to endometrial cancer is less than 5% over 20 years and that the majority of cases of endometrial hyperplasia without atypia will regress spontaneously during follow-up.
Reversible risk factors such as obesity and the use of HRT should be identified and addressed if possible.
Observation alone with follow-up endometrial biopsies to ensure disease regression can be considered, especially when identifiable risk factors can be reversed.
However, women should be informed that treatment with progestogens has a higher disease regression rate compared with observation alone. Progestogen treatment is indicated in women who fail to regress following observation alone and in symptomatic women with abnormal uterine bleeding.
Basically, you need to talk to the dr and ask some questions. You ought to be told of the options and be able to come to some agreement with your own wishes considered if the options are similar in efficacy.